These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30713996)

  • 21. Induction of Fos protein by antipsychotic drugs in rat brain following kainic acid-induced limbic-cortical neuronal loss.
    Roe DL; Bardgett ME; Csernansky CA; Csernansky JG
    Psychopharmacology (Berl); 1998 Jul; 138(2):151-8. PubMed ID: 9718284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Olanzapine-induced Fos expression in the rat forebrain; cross-tolerance with haloperidol and clozapine.
    Sebens JB; Koch T; Ter Horst GJ; Korf J
    Eur J Pharmacol; 1998 Jul; 353(1):13-21. PubMed ID: 9721035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different antipsychotics elicit different effects on magnocellular oxytocinergic and vasopressinergic neurons as revealed by Fos immunohistochemistry.
    Kiss A; Bundzikova J; Pirnik Z; Mikkelsen JD
    J Neurosci Res; 2010 Feb; 88(3):677-85. PubMed ID: 19774673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of mGlu2 in the 5-HT
    Hideshima KS; Hojati A; Saunders JM; On DM; de la Fuente Revenga M; Shin JM; Sánchez-González A; Dunn CM; Pais AB; Pais AC; Miles MF; Wolstenholme JT; González-Maeso J
    Psychopharmacology (Berl); 2018 Nov; 235(11):3149-3165. PubMed ID: 30209534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular and behavioral effects mediated by Gs-coupled adenosine A2a, but not serotonin 5-Ht4 or 5-Ht6 receptors following antipsychotic administration.
    Ward RP; Dorsa DM
    Neuroscience; 1999 Mar; 89(3):927-38. PubMed ID: 10199625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential expression of c-fos mRNA in rat prefrontal cortex, striatum, N. accumbens and lateral septum after typical and atypical antipsychotics: an in situ hybridization study.
    Semba J; Sakai M; Miyoshi R; Mataga N; Fukamauchi F; Kito S
    Neurochem Int; 1996 Oct; 29(4):435-42. PubMed ID: 8939453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute administration of typical and atypical antipsychotic drugs induces distinctive patterns of Fos expression in the rat forebrain.
    Wan W; Ennulat DJ; Cohen BM
    Brain Res; 1995 Aug; 688(1-2):95-104. PubMed ID: 8542328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. c-Fos expression in the hypothalamic paraventricular nucleus after a single treatment with a typical haloperidol and nine atypical antipsychotics: a pilot study.
    Kiss A
    Endocr Regul; 2018 Apr; 52(2):93-100. PubMed ID: 29715183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential patterns of induction of NGFI-B, Nor1 and c-fos mRNAs in striatal subregions by haloperidol and clozapine.
    Werme M; Ringholm A; Olson L; Brené S
    Brain Res; 2000 Apr; 863(1-2):112-9. PubMed ID: 10773199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atypical antipsychotic properties of blonanserin, a novel dopamine D2 and 5-HT2A antagonist.
    Ohno Y; Okano M; Imaki J; Tatara A; Okumura T; Shimizu S
    Pharmacol Biochem Behav; 2010 Aug; 96(2):175-80. PubMed ID: 20460137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Double activity imaging reveals distinct cellular targets of haloperidol, clozapine and dopamine D(3) receptor selective RGH-1756.
    Kovács KJ; Csejtei M; Laszlovszky I
    Neuropharmacology; 2001 Mar; 40(3):383-93. PubMed ID: 11166331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex.
    Gessa GL; Devoto P; Diana M; Flore G; Melis M; Pistis M
    Neuropsychopharmacology; 2000 Jun; 22(6):642-9. PubMed ID: 10788763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of antipsychotic drugs on neurotoxicity, expression of fos-like protein and c-fos mRNA in the retrosplenial cortex after administration of dizocilpine.
    Fujimura M; Hashimoto K; Yamagami K
    Eur J Pharmacol; 2000 Jun; 398(1):1-10. PubMed ID: 10856442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice.
    Gleason SD; Shannon HE
    Psychopharmacology (Berl); 1997 Jan; 129(1):79-84. PubMed ID: 9122367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increasing D2 affinity results in the loss of clozapine's atypical antipsychotic action.
    Kapur S; McClelland RA; VanderSpek SC; Wadenberg ML; Baker G; Nobrega J; Zipursky RB; Seeman P
    Neuroreport; 2002 May; 13(6):831-5. PubMed ID: 11997696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The discriminative stimulus properties of the atypical antipsychotic olanzapine in rats.
    Porter JH; McCallum SE; Varvel SA; Vann RE
    Psychopharmacology (Berl); 2000 Feb; 148(3):224-33. PubMed ID: 10755735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atypical antipsychotic drugs selectively increase neurotensin efflux in dopamine terminal regions.
    Radke JM; Owens MJ; Ritchie JC; Nemeroff CB
    Proc Natl Acad Sci U S A; 1998 Sep; 95(19):11462-4. PubMed ID: 9736759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atypical and typical neuroleptic treatments induce distinct programs of transcription factor expression in the striatum.
    Hiroi N; Graybiel AM
    J Comp Neurol; 1996 Oct; 374(1):70-83. PubMed ID: 8891947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antagonist functional selectivity: 5-HT2A serotonin receptor antagonists differentially regulate 5-HT2A receptor protein level in vivo.
    Yadav PN; Kroeze WK; Farrell MS; Roth BL
    J Pharmacol Exp Ther; 2011 Oct; 339(1):99-105. PubMed ID: 21737536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atypical neuroleptics enhance histamine turnover in brain via 5-Hydroxytryptamine2A receptor blockade.
    Morisset S; Sahm UG; Traiffort E; Tardivel-Lacombe J; Arrang JM; Schwartz JC
    J Pharmacol Exp Ther; 1999 Feb; 288(2):590-6. PubMed ID: 9918563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.